These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 20627463

  • 1. Antimicrobial activity of DW286 against Streptococcus pneumoniae.
    Park HS, Jung SJ, Choi DR, Kwak JH.
    Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
    Adam HJ, Schurek KN, Decorby MR, Weshnoweski B, Vashisht R, Karlowsky K, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
    [Abstract] [Full Text] [Related]

  • 3. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M, Giménez MJ, Vicente D, Aguilar L, Pérez-Trallero E.
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
    Park HS, Oh SH, Kim HS, Choi DR, Kwak JH.
    Molecules; 2016 Nov 17; 21(11):. PubMed ID: 27869677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG, James J, Derkatch S, Laing N, Noreddin AM, Hoban DJ.
    J Antimicrob Chemother; 2006 Jul 17; 58(1):112-6. PubMed ID: 16644764
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L, Manzor O, Pawlak J, Belian B.
    Int J Antimicrob Agents; 2005 Jul 17; 26(1):81-4. PubMed ID: 15951159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR, Min YH, Ryu JM, Choi DR, Shim MJ, Choi EC.
    J Antimicrob Chemother; 2006 Sep 17; 58(3):684-8. PubMed ID: 16873394
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
    Thornsberry C, Brown NP, Draghi DC, Evangelista AT, Yee YC, Sahm DF.
    Postgrad Med; 2008 Sep 17; 120(3 Suppl 1):32-8. PubMed ID: 18931469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.